Navigation Links
SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
Date:4/23/2009

San Diego, April 23 /PRNewswire-FirstCall/ -- SEQUENOM, Inc. (Nasdaq: SQNM), today announced that it will report first quarter 2009 financial results after market close on Thursday, April 30, 2009. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day.

    Conference Call Information:
    Domestic callers: 1 (866) 844-2998
    International callers: 1 (706) 679-9912

Webcast information: Visit the investor relations section at www.sequenom.com.

The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).

A webcast replay will be available on the SEQUENOM Web site for 14 days. A telephone replay will be available for 48 hours following the conclusion of the call by dialing (800) 642-1687 for domestic callers, or (706) 645-9291 for international callers, and entering reservation code 93862699.

About SEQUENOM

SEQUENOM is committed to providing the best genetic analysis products that translate the results of genomic science into solutions for noninvasive prenatal diagnostics, biomedical research, translational research and molecular medicine applications. The company's proprietary MassARRAY(R) system is a high-performance (in speed, accuracy and cost efficiency) nucleic acid analysis platform that quantitatively and precisely measures genetic target material and variations. The company has exclusively licensed intellectual property rights for the development and commercialization of noninvasive prenatal genetic tests for use with the MassARRAY system and other platforms. SEQUENOM maintains a website at www.sequenom.com to which SEQUENOM regularly posts copies of its press releases as well as additional information about SEQUENOM. Interested persons can subscribe on the SEQUENOM website to email alerts or RSS feeds that are sent automatically when SEQUENOM issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

SEQUENOM(R) and MassARRAY(R) are trademarks of SEQUENOM, Inc.

    Company Contact
    Ian Clements
    Sr. Director, Corp. Communications
    +1 (858) 202-9000

    Investor Relations Contact
    Lippert/Heilshorn & Associates
    Jody Cain (jcain@lhai.com)
    Kevin Mc Cabe (kmccabe@lhai.com)
    +1 (310) 691-7100

    Media Relations
    Pure Communications
    Sheryl Seapy
    +1 (949) 608-0841


'/>"/>
SOURCE SEQUENOM, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
2. Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3
3. Sequenom to Webcast Analyst and Investor Briefing Presentation on September 24
4. SENOMYX, INC. FIRST QUARTER 2009 EARNINGS CONFERENCE CALL SCHEDULED FOR MAY 7, 2009
5. Insmed to Host First Quarter 2009 Conference Call
6. Essilor : 2009 First Quarter Report
7. Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2009 Financial Results
8. Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast
9. ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009
10. SiliconSky GPS Designs First AGPS-Enabled Asthma Inhaler for Landmark Research Program
11. Z Therapy Is The First In North Texas To Offer Revolutionary Treatment Option For Neck Pain Sufferers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... 2016   ViaCyte, Inc ., a leading, ... stem cell-derived islet replacement therapy for the treatment ... announced that ViaCyte and Janssen Biotech, Inc., one ... Johnson, have agreed to consolidate the assets of ... provides ViaCyte with an exclusive license to all ...
(Date:2/3/2016)... Mass., Feb. 3, 2016 Harvard Apparatus ... biotechnology company developing bioengineered organ implants for life-threatening ... announced that CEO Jim McGorry , will ... Conference on Tuesday, February 9, 2016 at ... City . HART,s presentation will be webcast ...
(Date:2/3/2016)... ... February 03, 2016 , ... StarNet Communications ... solutions today announced the addition of a powerful “Session Preview” feature to its ... current state of the remote Linux desktop or other applications (sessions) they have ...
(Date:2/3/2016)... ... February 03, 2016 , ... ... aid in the rapid development and ongoing quality control of molecular assays targeting ... is extremely high,” Dr. Gregory R. Chiklis, President and CEO of ZeptoMetrix, relayed ...
Breaking Biology Technology:
(Date:1/22/2016)... , January 22, 2016 /PRNewswire/ ... announced the addition of the  "Global ... their offering. --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ... the  "Global Behavioral Biometric Market 2016-2020" ... Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) ...
(Date:1/20/2016)... Jan. 20, 2016  Synaptics Incorporated (NASDAQ: ... solutions, today announced sampling of S1423, its newest ... and small screen applications including smartwatches, fitness trackers, ... round and rectangular shapes, as well as thick ... with moisture on screen, while wearing gloves, and ...
(Date:1/11/2016)... , Jan. 11, 2016 Synaptics Incorporated ... interface solutions, today announced that its ClearPad ® ... (TDDI) products won two separate categories in the 8 ... Innovator and Best Technology Breakthrough. The Synaptics ® ... a simplified supply chain, thinner devices, brighter displays and ...
Breaking Biology News(10 mins):